Patents by Inventor Farjana FATTAH

Farjana FATTAH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240150836
    Abstract: The present disclosure generally relates to compositions and methods for predicting or diagnosing immune-related adverse events (irAE) before, during, or after immune checkpoint inhibitor (ICI) treatment in a subject with cancer. The method includes assessment of transcripts, autoantibody levels, cytokine levels, and immune cells. The irAE can be ICI-related myositis, ICI-related myocarditis or ICI-related myositis and myocarditis.
    Type: Application
    Filed: November 8, 2023
    Publication date: May 9, 2024
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Jason Y. Park, John David Farrar, David E. Gerber, Farjana Fattah, Hong Mu-Mosley
  • Publication number: 20230288415
    Abstract: The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy-induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.
    Type: Application
    Filed: December 7, 2022
    Publication date: September 14, 2023
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Edward K. Wakeland, David E. Gerber, Quanzhen Li, Shaheen Khan, Saad Khan, Yang Xie, Jason Y. Park, Farjana Fattah, Xin Luo
  • Publication number: 20210263045
    Abstract: The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy—induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.
    Type: Application
    Filed: April 8, 2019
    Publication date: August 26, 2021
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Edward WAKELAND, David E. GERBER, Quan LI, Shaheen KHAN, Saad KHAN, Yang XIE, Jason Y. Park, Farjana FATTAH, Xin LUO